Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 5/20 | 0.52 |
| ▸ | FNTB | P49356 | 5/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.48 |
| ▸ | MEN1 | O00255 | 3/20 | 0.47 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | CASP3 | P42574 | 1/20 | 0.41 |
| ▸ | CASP7 | P55210 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8873499 | 0.89 | FNTA (0.57) | FNTAFNTBKMT2AMEN1SIGMAR1 | |
| SCHEMBL8874595 | 0.89 | FNTA (0.57) | FNTAFNTBKMT2AMEN1SIGMAR1 | |
| SCHEMBL8873556 | 0.81 | FNTA (0.52) | FNTAFNTBKMT2AMEN1SIGMAR1 | |
| SCHEMBL8875074 | 0.80 | FNTA (0.54) | FNTAFNTBKMT2AMEN1SIGMAR1 | |
| SCHEMBL8875081 | 0.80 | FNTA (0.54) | FNTAFNTBKMT2AMEN1SIGMAR1 | |
| SCHEMBL8875314 | 0.79 | FNTA (0.52) | FNTAFNTBKMT2AMEN1SIGMAR1 | |
| Hydrochloric Acid SCHEMBL8873794 | 0.78 | FNTA (0.52) | FNTAFNTBKMT2AMEN1SIGMAR1 | |
| SCHEMBL8875525 | 0.78 | FNTA (0.51) | FNTAFNTBKMT2AMEN1SIGMAR1 | |
| SCHEMBL8874803 | 0.78 | FNTA (0.56) | FNTAFNTBKMT2AMEN1SIGMAR1 | |
| SCHEMBL8874686 | 0.77 | FNTA (0.60) | FNTAFNTBKMT2AMEN1SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5624950-A | USEFUL IN TREATMENT OF ANALGESIA, INFLAMMATION, ASTHMA, ALLERGIES, CENTRAL NERVOUS SYSTEM DISORDERS, CARDIOVASCULAR DISORDERS, IMMUNE SYSTEM DISORDERS, ANTISPASMODIC AGENTS, ANTIEMETIC AGENTS | RHONE-POULENC RORER S.A. (FR) | 1997-04-29 | — | — | US | disclosed |